Literature DB >> 12067842

Regulation of the human brain natriuretic peptide gene by GATA-4.

Quan He1, Mariela Mendez, Margot C LaPointe.   

Abstract

Brain natriuretic peptide (BNP) is a cardiac hormone constitutively expressed in the adult heart. We previously showed that the human BNP (hBNP) proximal promoter region from -127 to -40 confers myocyte-specific expression. The proximal hBNP promoter contains several putative cis elements. Here we tested whether the proximal GATA element plays a role in basal and inducible regulation of the hBNP promoter. The hBNP promoter was coupled to a luciferase reporter gene (1818hBNPLuc) and transferred into neonatal ventricular myocytes (NVM), and luciferase activity was measured as an index of hBNP promoter activity. Mutation of the putative GATA element at -85 of the hBNP promoter [1818(mGATA)hBNPLuc] reduced activity by 97%. To study transactivation of the hBNP promoter, we co-transfected 1818hBNPLuc with the GATA-4 expression vector. GATA-4 activated 1818hBNPLuc, and this effect was eliminated by mutation of the proximal GATA element. Electrophoretic mobility shift assay showed that an oligonucleotide containing the hBNP GATA motif bound to cardiomyocyte nuclear protein, which was competed for by a consensus GATA oligonucleotide but not a mutated hBNP GATA element. The beta-adrenergic agonist isoproterenol and its second messenger cAMP stimulated hBNP promoter activity and binding of nuclear protein to the proximal GATA element. Thus the GATA element in the proximal hBNP promoter is involved in both basal and inducible transcriptional regulation in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067842     DOI: 10.1152/ajpendo.00274.2001

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  9 in total

1.  Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study.

Authors:  Jennifer E Ho; Daniel Levy; Lynda Rose; Andrew D Johnson; Paul M Ridker; Daniel I Chasman
Journal:  J Hypertens       Date:  2011-01       Impact factor: 4.844

2.  The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes.

Authors:  Andrew J Bingham; Lezanne Ooi; Lukasz Kozera; Edward White; Ian C Wood
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

3.  Predisposition to atrioventricular septal defects may be caused by SOX7 variants that impair interaction with GATA4.

Authors:  Baolei Li; Zhuoyan Li; Jianping Yang; Nanchao Hong; Lihui Jin; Yuejuan Xu; Qihua Fu; Kun Sun; Yu Yu; Yanan Lu; Sun Chen
Journal:  Mol Genet Genomics       Date:  2022-03-09       Impact factor: 3.291

4.  Pharmacogenetics of Addiction Therapy.

Authors:  David P Graham; Mark J Harding; David A Nielsen
Journal:  Methods Mol Biol       Date:  2022

5.  PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes.

Authors:  Quan He; Pamela Harding; Margot C LaPointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

6.  Association of GATA4 sequence variation with alcohol dependence.

Authors:  Victor M Karpyak; Stacey J Winham; Joanna M Biernacka; Julie M Cunningham; Kriste A Lewis; Jennifer R Geske; Colin L Colby; Osama A Abulseoud; Daniel K Hall-Flavin; Larissa L Loukianova; Terry D Schneekloth; Mark A Frye; John A Heit; David A Mrazek
Journal:  Addict Biol       Date:  2012-08-02       Impact factor: 4.280

7.  Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.

Authors:  Marianne K O Grant; Davis M Seelig; Leslie C Sharkey; Beshay N Zordoky
Journal:  Biol Sex Differ       Date:  2017-01-07       Impact factor: 5.027

8.  Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes.

Authors:  Itaru Goto; Ryuji Okamoto; Ryotaro Hashizume; Noboru Suzuki; Rie Ito; Keiichi Yamanaka; Hiromitsu Saito; Hiroshi Kiyonari; Isao Tawara; Yuki Kageyama; Yoshito Ogihara; Yusuf Ali; Norikazu Yamada; Naoyuki Katayama; Masaaki Ito
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

9.  ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.

Authors:  Rudolf A de Boer; Dirk J van Veldhuisen
Journal:  Cardiovasc Drugs Ther       Date:  2008-04-17       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.